Evidence-based management of lipid disorders /:
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Harley :
TFM,
2010.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource (326 pages) : illustrations (chiefly color) |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781908986597 190898659X |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn874146249 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 090819s2010 enka ob 001 0 eng d | ||
| 040 | |a E7B |b eng |e rda |e pn |c E7B |d OCLCO |d N$T |d YDXCP |d IDEBK |d EBLCP |d OCLCQ |d D6H |d COCUF |d AGLDB |d MOR |d CCO |d PIFPO |d ZCU |d MERUC |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCO |d OCLCF |d STF |d VNS |d OCLCO |d VTS |d NRAMU |d EZ9 |d ICG |d VT2 |d TOF |d OCLCQ |d WYU |d OCLCO |d OCLCA |d TKN |d OCLCO |d DKC |d OCLCO |d OCLCQ |d M8D |d UKAHL |d OCLCQ |d OCLCA |d AJS |d HS0 |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d UEJ |d OCLCQ | ||
| 015 | |a GBA989346 |2 bnb | ||
| 016 | 7 | |a 015366929 |2 Uk | |
| 019 | |a 868069186 |a 869435448 |a 923424667 |a 961550334 |a 962576901 |a 1055319069 |a 1065697270 |a 1081260219 |a 1227639229 | ||
| 020 | |a 9781908986597 |q (e-book) | ||
| 020 | |a 190898659X |q (e-book) | ||
| 020 | |z 9781903378717 | ||
| 020 | |z 1903378710 | ||
| 035 | |a (OCoLC)874146249 |z (OCoLC)868069186 |z (OCoLC)869435448 |z (OCoLC)923424667 |z (OCoLC)961550334 |z (OCoLC)962576901 |z (OCoLC)1055319069 |z (OCoLC)1065697270 |z (OCoLC)1081260219 |z (OCoLC)1227639229 | ||
| 050 | 4 | |a RC632.L5 |b V57 2010eb | |
| 060 | 4 | |a 2010 I-616 | |
| 060 | 4 | |a WD 200.5.H8 |b E93 2010 | |
| 060 | 4 | |a WD 200.5.H8 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 7 | |a 616.399706 |2 22 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Evidence-based management of lipid disorders / |c Maud N. Vissers, John J.P. Kastelein, Erik S. Stroes, [editors]. |
| 264 | 1 | |a Harley : |b TFM, |c 2010. | |
| 300 | |a 1 online resource (326 pages) : |b illustrations (chiefly color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Després -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma. | |
| 546 | |a English. | ||
| 650 | 0 | |a Lipids |x Metabolism |x Disorders |x Treatment. | |
| 650 | 0 | |a Evidence-based medicine. |0 http://id.loc.gov/authorities/subjects/sh97007984 | |
| 650 | 1 | 2 | |a Lipid Metabolism Disorders |x therapy |
| 650 | 2 | |a Evidence-Based Practice |0 https://id.nlm.nih.gov/mesh/D055317 | |
| 650 | 2 | 2 | |a Evidence-Based Medicine |
| 650 | 6 | |a Médecine factuelle. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Evidence-based medicine |2 fast | |
| 700 | 1 | |a Vissers, Maud N. | |
| 700 | 1 | |a Kastelein, John J. P. | |
| 700 | 1 | |a Stroes, Erik S. | |
| 758 | |i has work: |a Evidence-based management of lipid disorders (Text) |1 https://id.oclc.org/worldcat/entity/E39PCYGKtWyMR6VVJYGJYKKdCj |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Evidence-based management of lipid disorders. |d Harley : TFM, 2010 |h x, 314 pages : illustrations (chiefly color) ; 25 cm. |z 9781903378717 |w (DLC) 2010459387 |w (OCoLC)244766419 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=685402 |3 Volltext |
| 936 | |a BATCHLOAD | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH26970781 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH26152004 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL3410357 | ||
| 938 | |a ebrary |b EBRY |n ebr10827988 | ||
| 938 | |a EBSCOhost |b EBSC |n 685402 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n cis27569286 | ||
| 938 | |a YBP Library Services |b YANK |n 11574740 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn874146249 |
|---|---|
| _version_ | 1816882264840077313 |
| adam_text | |
| any_adam_object | |
| author2 | Vissers, Maud N. Kastelein, John J. P. Stroes, Erik S. |
| author2_role | |
| author2_variant | m n v mn mnv j j p k jjp jjpk e s s es ess |
| author_facet | Vissers, Maud N. Kastelein, John J. P. Stroes, Erik S. |
| author_sort | Vissers, Maud N. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC632 |
| callnumber-raw | RC632.L5 V57 2010eb |
| callnumber-search | RC632.L5 V57 2010eb |
| callnumber-sort | RC 3632 L5 V57 42010EB |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Després -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma. |
| ctrlnum | (OCoLC)874146249 |
| dewey-full | 616.399706 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.399706 |
| dewey-search | 616.399706 |
| dewey-sort | 3616.399706 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05666cam a2200781 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn874146249</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">090819s2010 enka ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">E7B</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">E7B</subfield><subfield code="d">OCLCO</subfield><subfield code="d">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">IDEBK</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">D6H</subfield><subfield code="d">COCUF</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">CCO</subfield><subfield code="d">PIFPO</subfield><subfield code="d">ZCU</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">STF</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VTS</subfield><subfield code="d">NRAMU</subfield><subfield code="d">EZ9</subfield><subfield code="d">ICG</subfield><subfield code="d">VT2</subfield><subfield code="d">TOF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">TKN</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">M8D</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">AJS</subfield><subfield code="d">HS0</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">UEJ</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBA989346</subfield><subfield code="2">bnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">015366929</subfield><subfield code="2">Uk</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">868069186</subfield><subfield code="a">869435448</subfield><subfield code="a">923424667</subfield><subfield code="a">961550334</subfield><subfield code="a">962576901</subfield><subfield code="a">1055319069</subfield><subfield code="a">1065697270</subfield><subfield code="a">1081260219</subfield><subfield code="a">1227639229</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781908986597</subfield><subfield code="q">(e-book)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">190898659X</subfield><subfield code="q">(e-book)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781903378717</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1903378710</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)874146249</subfield><subfield code="z">(OCoLC)868069186</subfield><subfield code="z">(OCoLC)869435448</subfield><subfield code="z">(OCoLC)923424667</subfield><subfield code="z">(OCoLC)961550334</subfield><subfield code="z">(OCoLC)962576901</subfield><subfield code="z">(OCoLC)1055319069</subfield><subfield code="z">(OCoLC)1065697270</subfield><subfield code="z">(OCoLC)1081260219</subfield><subfield code="z">(OCoLC)1227639229</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC632.L5</subfield><subfield code="b">V57 2010eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2010 I-616</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WD 200.5.H8</subfield><subfield code="b">E93 2010</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WD 200.5.H8</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">014000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">022000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">112000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">045000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.399706</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Evidence-based management of lipid disorders /</subfield><subfield code="c">Maud N. Vissers, John J.P. Kastelein, Erik S. Stroes, [editors].</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Harley :</subfield><subfield code="b">TFM,</subfield><subfield code="c">2010.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (326 pages) :</subfield><subfield code="b">illustrations (chiefly color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Després -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Lipids</subfield><subfield code="x">Metabolism</subfield><subfield code="x">Disorders</subfield><subfield code="x">Treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Evidence-based medicine.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh97007984</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Lipid Metabolism Disorders</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Evidence-Based Practice</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D055317</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Evidence-Based Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médecine factuelle.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">General.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Clinical Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Diseases.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Evidence-Based Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Internal Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Evidence-based medicine</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vissers, Maud N.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kastelein, John J. P.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stroes, Erik S.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Evidence-based management of lipid disorders (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCYGKtWyMR6VVJYGJYKKdCj</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Evidence-based management of lipid disorders.</subfield><subfield code="d">Harley : TFM, 2010</subfield><subfield code="h">x, 314 pages : illustrations (chiefly color) ; 25 cm.</subfield><subfield code="z">9781903378717</subfield><subfield code="w">(DLC) 2010459387</subfield><subfield code="w">(OCoLC)244766419</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=685402</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="936" ind1=" " ind2=" "><subfield code="a">BATCHLOAD</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH26970781</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH26152004</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3410357</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10827988</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">685402</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">cis27569286</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">11574740</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn874146249 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:25:51Z |
| institution | BVB |
| isbn | 9781908986597 190898659X |
| language | English |
| oclc_num | 874146249 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (326 pages) : illustrations (chiefly color) |
| psigel | ZDB-4-EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | TFM, |
| record_format | marc |
| spelling | Evidence-based management of lipid disorders / Maud N. Vissers, John J.P. Kastelein, Erik S. Stroes, [editors]. Harley : TFM, 2010. 1 online resource (326 pages) : illustrations (chiefly color) text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references and index. Print version record. How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Després -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma. English. Lipids Metabolism Disorders Treatment. Evidence-based medicine. http://id.loc.gov/authorities/subjects/sh97007984 Lipid Metabolism Disorders therapy Evidence-Based Practice https://id.nlm.nih.gov/mesh/D055317 Evidence-Based Medicine Médecine factuelle. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Evidence-based medicine fast Vissers, Maud N. Kastelein, John J. P. Stroes, Erik S. has work: Evidence-based management of lipid disorders (Text) https://id.oclc.org/worldcat/entity/E39PCYGKtWyMR6VVJYGJYKKdCj https://id.oclc.org/worldcat/ontology/hasWork Print version: Evidence-based management of lipid disorders. Harley : TFM, 2010 x, 314 pages : illustrations (chiefly color) ; 25 cm. 9781903378717 (DLC) 2010459387 (OCoLC)244766419 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=685402 Volltext |
| spellingShingle | Evidence-based management of lipid disorders / How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Després -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma. Lipids Metabolism Disorders Treatment. Evidence-based medicine. http://id.loc.gov/authorities/subjects/sh97007984 Lipid Metabolism Disorders therapy Evidence-Based Practice https://id.nlm.nih.gov/mesh/D055317 Evidence-Based Medicine Médecine factuelle. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Evidence-based medicine fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh97007984 https://id.nlm.nih.gov/mesh/D055317 |
| title | Evidence-based management of lipid disorders / |
| title_auth | Evidence-based management of lipid disorders / |
| title_exact_search | Evidence-based management of lipid disorders / |
| title_full | Evidence-based management of lipid disorders / Maud N. Vissers, John J.P. Kastelein, Erik S. Stroes, [editors]. |
| title_fullStr | Evidence-based management of lipid disorders / Maud N. Vissers, John J.P. Kastelein, Erik S. Stroes, [editors]. |
| title_full_unstemmed | Evidence-based management of lipid disorders / Maud N. Vissers, John J.P. Kastelein, Erik S. Stroes, [editors]. |
| title_short | Evidence-based management of lipid disorders / |
| title_sort | evidence based management of lipid disorders |
| topic | Lipids Metabolism Disorders Treatment. Evidence-based medicine. http://id.loc.gov/authorities/subjects/sh97007984 Lipid Metabolism Disorders therapy Evidence-Based Practice https://id.nlm.nih.gov/mesh/D055317 Evidence-Based Medicine Médecine factuelle. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Evidence-based medicine fast |
| topic_facet | Lipids Metabolism Disorders Treatment. Evidence-based medicine. Lipid Metabolism Disorders therapy Evidence-Based Practice Evidence-Based Medicine Médecine factuelle. HEALTH & FITNESS Diseases General. MEDICAL Clinical Medicine. MEDICAL Diseases. MEDICAL Evidence-Based Medicine. MEDICAL Internal Medicine. Evidence-based medicine |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=685402 |
| work_keys_str_mv | AT vissersmaudn evidencebasedmanagementoflipiddisorders AT kasteleinjohnjp evidencebasedmanagementoflipiddisorders AT stroeseriks evidencebasedmanagementoflipiddisorders |